Cargando…

Prognostic factors for survival in soft tissue sarcoma.

Between 1975 and 1984, 125 cases of histologically confirmed soft tissue sarcomata (STS) were registered in the Department of Clinical Oncology in Edinburgh. Of these, 100 were eligible for analysis of prognostic factors. The overall 5-year survival rate was 21.5%. Univariate analysis demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: el-Jabbour, J. N., Akhtar, S. S., Kerr, G. R., McLaren, K. M., Smyth, J. F., Rodger, A., Leonard, R. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971531/
https://www.ncbi.nlm.nih.gov/pubmed/2245181
_version_ 1782134930402181120
author el-Jabbour, J. N.
Akhtar, S. S.
Kerr, G. R.
McLaren, K. M.
Smyth, J. F.
Rodger, A.
Leonard, R. C.
author_facet el-Jabbour, J. N.
Akhtar, S. S.
Kerr, G. R.
McLaren, K. M.
Smyth, J. F.
Rodger, A.
Leonard, R. C.
author_sort el-Jabbour, J. N.
collection PubMed
description Between 1975 and 1984, 125 cases of histologically confirmed soft tissue sarcomata (STS) were registered in the Department of Clinical Oncology in Edinburgh. Of these, 100 were eligible for analysis of prognostic factors. The overall 5-year survival rate was 21.5%. Univariate analysis demonstrated that extent of surgery, radical versus palliative or no radiotherapy, mass as a presenting symptom, metastases at presentation, site, histological type, mitotic activity, grade and UICC stage all had a statistically significant effect on survival. Analysis using the proportional hazard regression model was performed on the 87 patients for whom all variables were recorded. When all histological and clinical features and treatment modalities were included in the model then radiotherapy, surgery, necrosis, sex and mitoses were identified as independent prognostic variables. When symptoms and treatment were excluded then the multivariate analysis identified sex and mitotic activity as independent parameters. For the 33 superficial STS with tumour size recorded multivariate analysis revealed size, necrosis and cellularity as independent prognostic variables. For the 31 deep STS histological type, sex, surgery and radiotherapy were identified as independent prognostic parameters.
format Text
id pubmed-1971531
institution National Center for Biotechnology Information
language English
publishDate 1990
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19715312009-09-10 Prognostic factors for survival in soft tissue sarcoma. el-Jabbour, J. N. Akhtar, S. S. Kerr, G. R. McLaren, K. M. Smyth, J. F. Rodger, A. Leonard, R. C. Br J Cancer Research Article Between 1975 and 1984, 125 cases of histologically confirmed soft tissue sarcomata (STS) were registered in the Department of Clinical Oncology in Edinburgh. Of these, 100 were eligible for analysis of prognostic factors. The overall 5-year survival rate was 21.5%. Univariate analysis demonstrated that extent of surgery, radical versus palliative or no radiotherapy, mass as a presenting symptom, metastases at presentation, site, histological type, mitotic activity, grade and UICC stage all had a statistically significant effect on survival. Analysis using the proportional hazard regression model was performed on the 87 patients for whom all variables were recorded. When all histological and clinical features and treatment modalities were included in the model then radiotherapy, surgery, necrosis, sex and mitoses were identified as independent prognostic variables. When symptoms and treatment were excluded then the multivariate analysis identified sex and mitotic activity as independent parameters. For the 33 superficial STS with tumour size recorded multivariate analysis revealed size, necrosis and cellularity as independent prognostic variables. For the 31 deep STS histological type, sex, surgery and radiotherapy were identified as independent prognostic parameters. Nature Publishing Group 1990-11 /pmc/articles/PMC1971531/ /pubmed/2245181 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
el-Jabbour, J. N.
Akhtar, S. S.
Kerr, G. R.
McLaren, K. M.
Smyth, J. F.
Rodger, A.
Leonard, R. C.
Prognostic factors for survival in soft tissue sarcoma.
title Prognostic factors for survival in soft tissue sarcoma.
title_full Prognostic factors for survival in soft tissue sarcoma.
title_fullStr Prognostic factors for survival in soft tissue sarcoma.
title_full_unstemmed Prognostic factors for survival in soft tissue sarcoma.
title_short Prognostic factors for survival in soft tissue sarcoma.
title_sort prognostic factors for survival in soft tissue sarcoma.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971531/
https://www.ncbi.nlm.nih.gov/pubmed/2245181
work_keys_str_mv AT eljabbourjn prognosticfactorsforsurvivalinsofttissuesarcoma
AT akhtarss prognosticfactorsforsurvivalinsofttissuesarcoma
AT kerrgr prognosticfactorsforsurvivalinsofttissuesarcoma
AT mclarenkm prognosticfactorsforsurvivalinsofttissuesarcoma
AT smythjf prognosticfactorsforsurvivalinsofttissuesarcoma
AT rodgera prognosticfactorsforsurvivalinsofttissuesarcoma
AT leonardrc prognosticfactorsforsurvivalinsofttissuesarcoma